A Remedy for Age-Related Muscle Loss: Immunis’ Hans Keirstead

About this episode

The episode features an interview with Hans Keirstead discussing Immunis' innovative therapies for age-related muscle loss.

In this episode, we speak with Hans Keirstead, Chairman of the Board at Immunis, a clinical-stage biotechnology company developing stem cell-derived biologics to address age-related diseases and immune dysfunction. Immunis’ investigational therapy, IMM01-STEM, is a stem cell-derived secretome designed to modulate immune health and improve muscle mass and function, with initial clinical work focused on sarcopenia-related conditions. Hans is a stem cell researcher and biotech entrepreneur with prior experience developing therapies across neurology, immune disorders, and oncology. He previously served as a full professor of anatomy and neurobiology at UC Irvine and has held leadership and board roles across multiple biotechnology organizations. I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.

People in this episode

Host: RJ Lumba

Guest: Hans Keirstead

Topics covered

• age-related diseases
• biotechnology
• stem cell research
• muscle health
• immune dysfunction

Keywords

• muscle loss
• sarcopenia
• stem cell-derived biologics
• immune health
• biotech entrepreneur

Mentioned in this episode

Organizations: Immunis, UC Irvine

More episodes of Great Entrepreneurs with RJ Lumba

• Real-Time Life Insurance Underwriting: Ladder’s Jamie Hale · March 11, 2026 · 19 min
• Connecting Capital to Housing: Avenue One’s Ryan Stroker · February 18, 2026 · 24 min
• Technology for Financial Health: Achieve’s Brad Stroh · February 4, 2026 · 23 min
• Expanding Autism Care Access: Positive Development’s Mike Suiters · January 21, 2026 · 20 min
• Consumer FinTech Leader: Upgrade’s Renaud Laplanche · January 7, 2026 · 16 min
• Modernizing Insurance Shopping: Insurify’s Snejina Zacharia · December 17, 2025 · 23 min